Stock data
Novavax, Inc. (NVAX)
Novavax, Inc. (NVAX) reported revenue of US$1.12B and net income of US$440.30M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.12B | — | US$452.80M | US$440.30M | — |
| 2024 | US$682.16M | — | -US$248.93M | -US$187.50M | — |
| 2023 | US$983.71M | — | -US$566.51M | -US$545.06M | — |
| 2022 | US$1.98B | — | -US$644.74M | -US$657.94M | — |
| 2021 | US$1.15B | — | -US$1.69B | -US$1.74B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$56.70M | -US$53.39M | — |
| 2026-03-31 | US$139.51M | -US$9.49M | — |
| 2025-12-31 | US$147.14M | US$17.53M | — |
| 2025-09-30 | US$70.44M | -US$202.38M | — |
| 2025-06-30 | US$239.24M | US$106.51M | — |
| 2025-03-31 | US$666.65M | US$518.65M | — |
| 2024-12-31 | US$88.31M | -US$81.03M | — |
| 2024-09-30 | US$84.51M | -US$121.30M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.